Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Quoin Pharmaceuticals, Ltd.

Get SEC filing alerts via email and in your feed for Quoin Pharmaceuticals, Ltd.

QNRX

Quoin Pharmaceuticals, Ltd.

About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals Ltd. is a late-stage specialty pharmaceutical company focused on developing and commercializing treatments for rare and orphan diseases, primarily in dermatology. Its pipeline includes products like QRX003 for Netherton Syndrome, utilizing proprietary drug delivery technologies. The company targets global markets through partnerships, aiming to address unmet medical needs with innovative, regulatory-approved therapies for small patient populations.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Quoin Pharmaceuticals, Ltd.

1
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports Increased Net Loss and Decline in Total Assets for Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports $15.8 Million Net Loss and Advances QRX003 Clinical Development

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports $3.95 Million Net Loss and Increased R&D Expenses in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports $3.7 Million Net Loss and Increased R&D Spending in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports $3.8 Million Net Loss in Q1 2025, Increases R&D Spending

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports $8.96 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Quoin Pharmaceuticals, Ltd. Quoin Pharmaceuticals Reports Net Loss of $6.7M for Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments